Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析

◆英語タイトル:Median Technologies SA (ALMDT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14469
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed services and investigator site network services. Its imaging services include regulations compliance, project management, data management and quality control, biostatistics and data analysis, and IT services. Median’s clinical trial services comprise imaging protocol design, site training and management, radiological review, imaging biomarkers, image analysis and reporting, and others. The company develops iBiopsy, a phenomics platform designed to acquire, index, and analyze individual phenotypes. It markets its solutions to pharmaceutical companies, healthcare institutions, hospitals, and cancer clinics. The company has operations in France and the US. Median is headquartered in Valbonne, France.

Median Technologies SA Key Recent Developments

Feb 07,2019: Median Technologies provides a company update and announces preliminary full year 2018 unaudited financial results
Oct 11,2018: Median Technologies Reports Its Financial Results for H1 2018 and Announces Its Strategic Shift in Focus to Its Imaging Phenomics Platform iBiopsy®
Oct 11,2018: Median Technologies Reports its Financial Results for H1 2018
Jul 12,2018: Median Technologies Receives the Forbes 2018 Futur40 Award and Special Recognition Prize for the “Health-Life Sciences” Company Category
May 24,2018: Median Technologies Appoints Dr. Yan Liu as Medical Director, Europe

This comprehensive SWOT profile of Median Technologies SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Median Technologies SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Median Technologies SA – Key Information
Median Technologies SA – Overview
Median Technologies SA – Key Employees
Median Technologies SA – Key Employee Biographies
Median Technologies SA – Key Operational Heads
Median Technologies SA – Major Products and Services
Median Technologies SA – History
Median Technologies SA – Company Statement
Median Technologies SA – Locations And Subsidiaries
Median Technologies SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Median Technologies SA – Business Description
Median Technologies SA – Corporate Strategy
Median Technologies SA – SWOT Analysis
SWOT Analysis – Overview
Median Technologies SA – Strengths
Median Technologies SA – Weaknesses
Median Technologies SA – Opportunities
Median Technologies SA – Threats
Median Technologies SA – Key Competitors

Section 3 – Company Financial Performance Charts

Median Technologies SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Median Technologies SA, Key Information
Median Technologies SA, Key Ratios
Median Technologies SA, Share Data
Median Technologies SA, Major Products and Services
Median Technologies SA, History
Median Technologies SA, Key Employees
Median Technologies SA, Key Employee Biographies
Median Technologies SA, Key Operational Heads
Median Technologies SA, Other Locations
Median Technologies SA, Subsidiaries
Median Technologies SA, Key Manufacturing facilities
Median Technologies SA, Key Competitors
Median Technologies SA, SWOT Analysis
Median Technologies SA, Ratios based on current share price
Median Technologies SA, Annual Ratios
Median Technologies SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Median Technologies SA, Performance Chart
Median Technologies SA, Ratio Charts

★海外企業調査レポート[Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …
  • Modern Times Group MTG AB:企業のM&A・事業提携・投資動向
    Modern Times Group MTG AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Modern Times Group MTG AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company. It focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment …
  • Atos SE:企業のM&A・事業提携・投資動向
    Atos SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atos SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • ReWalk Robotics Ltd (RWLK):企業の製品パイプライン分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • PulteGroup, Inc.:企業の戦略・SWOT・財務情報
    PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Net Insight AB (NETI B):企業の財務・戦略的SWOT分析
    Net Insight AB (NETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mentor Graphics Corporation:企業のM&A・事業提携・投資動向
    Mentor Graphics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mentor Graphics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Electricity Supply Board:企業の発電所・SWOT分析2018
    Electricity Supply Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Lotus Bakeries NV:企業の戦略・SWOT・財務情報
    Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report Summary Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its products are used for the ther …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a bio pharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • Anheuser-Busch InBev NVSA (ABI):企業の財務・戦略的SWOT分析
    Anheuser-Busch InBev NVSA (ABI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PositiveID Corp (PSID):企業の財務・戦略的SWOT分析
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous …
  • The National Bank of Ras Al-Khaimah (P.S.C.):企業の戦略・SWOT・財務分析
    The National Bank of Ras Al-Khaimah (P.S.C.) - Strategy, SWOT and Corporate Finance Report Summary The National Bank of Ras Al-Khaimah (P.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Porto Seguro SA:企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆